Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01490086 | RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder | PHASE2 | COMPLETED | 234 | — | — | Dec 1, 2011 | Mar 1, 2013 | Aug 7, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| RP5063 | DRUG | daily |
| placebo | DRUG | daily |
| aripiprazole | DRUG | daily |